Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Sees Significant Increase in Short Interest

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) saw a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 23,657 shares, an increase of 1,351.3% from the July 30th total of 1,630 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Analysts Set New Price Targets

Separately, Morgan Stanley upgraded shares of Towa Pharmaceutical to an “overweight” rating in a research report on Friday, June 12th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Towa Pharmaceutical presently has an average rating of “Buy”.

Institutional Trading of Towa Pharmaceutical

An institutional investor recently bought a new position in Towa Pharmaceutical stock. Public Employees Retirement System of Ohio purchased a new position in shares of Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 96,968 shares of the company’s stock, valued at approximately $3,285,000.

Towa Pharmaceutical Price Performance

Shares of OTCMKTS TWAPF remained flat at $25.98 during midday trading on Tuesday. The company’s 50-day simple moving average is $25.80 and its two-hundred day simple moving average is $25.50. Towa Pharmaceutical has a 52 week low of $25.71 and a 52 week high of $26.00.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.